HCID 67959087, Verbindung → 8-(3-Methoxyphenyl)-2-methyl-2,3,4,5-tetrahydrothieno[2,3-f][1,4]oxazepine
Reaktionsgleichung
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:9]2[C:18]3[O:17][CH:16]([CH3:19])[CH2:15][N:14](C(OC(C)(C)C)=O)[CH2:13][C:12]=3[S:11][CH:10]=2)[CH:6]=[CH:7][CH:8]=1>C(OCC)(=O)C.Cl>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:9]2[C:18]3[O:17][CH:16]([CH3:19])[CH2:15][NH:14][CH2:13][C:12]=3[S:11][CH:10]=2)[CH:6]=[CH:7][CH:8]=1Komponenten
3
Edukt 1
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
tert-Butyl 8-(3-methoxyphenyl)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepine-4(5H)-carboxylate (287 mg) was stirred in 4 N hydrogen chloride-ethyl acetate solution (5 mL) for 30 min. The reaction solution was concentrated under reduced pressure, and the residue was recrystallized from ethyl acetate to give 8-(3-methoxyphenyl)-2-methyl-2,3,4,5-tetrahydrothieno[2,3-f][1,4]oxazepine 1 hydrochloride (220 mg, 92%) as colorless crystals.
Aufarbeitung
- concentrationThe reaction solution was concentrated under reduced pressure
- customthe residue was recrystallized from ethyl acetate
Quellen und Nachweise
- ORD-Eintrag
- ord-c75567506de947e88348ddd6dc8d14c4
- Quelldatensatz
- uspto-grants-2014_12
- Patentnummer
- US08916549B2
Notizen zur Reaktion
Wird geladen…